Literature DB >> 15827849

Management of ascites after radical surgery in gastric cancer patients with liver cirrhosis and minimal hepatic dysfunction.

Keun Won Ryu1, Jun Ho Lee, Young Woo Kim, Joong-Won Park, Jae-Moon Bae.   

Abstract

A radical lymph node dissection is important for the cure of gastric cancer. However, such a procedure in patients with liver cirrhosis (LC) could develop serious complications such as massive ascites. To determine the management of postoperative ascites, 26 gastric cancer patients with LC were reviewed retrospectively. Child-Pugh status was grade A in all 26 patients. Thirteen (50%) patients had advanced gastric cancer, and a D2 lymph nodes dissection was performed in 25 (96.2%) patients. The mean number of dissected lymph nodes was 33 +/- 11 (range: 11-54). An abdominal closed suction drain was placed in 12 (46.2%) patients, and the average amount of fluid drainage was 463 ml/day. The drainage tube was removed on about the eleventh postoperative day (range: day 6 to day 13), and diuretics were used in 8 (30.8%) patients. A paracentesis was needed in one patient but no postoperative surgical morbidity or mortality was observed. Therefore, an extended lymph node dissection is safe in gastric cancer patients with mild hepatic dysfunction. Liver cirrhosis and postoperative ascites can be managed conservatively without any complications.

Entities:  

Mesh:

Year:  2005        PMID: 15827849     DOI: 10.1007/s00268-005-7715-2

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  16 in total

1.  Regeneration of lymphatic vessels: a radiographic study.

Authors:  C DANESE; J M HOWARD; R BOWER
Journal:  Ann Surg       Date:  1962-07       Impact factor: 12.969

2.  Improving survival in patients with cirrhosis undergoing major abdominal operations.

Authors:  K R Sirinek; R R Burk; M Brown; B A Levine
Journal:  Arch Surg       Date:  1987-03

3.  Benefits of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastases.

Authors:  J R Siewert; R Kestlmeier; R Busch; K Böttcher; J D Roder; J Müller; C Fellbaum; H Höfler
Journal:  Br J Surg       Date:  1996-08       Impact factor: 6.939

4.  Intractable ascites following surgery for gastric carcinoma.

Authors:  K Kumagai
Journal:  Dig Surg       Date:  1998       Impact factor: 2.588

5.  Cholecystectomy in patients with cirrhosis. A surgical challenge.

Authors:  R S Bloch; R D Allaben; A J Walt
Journal:  Arch Surg       Date:  1985-06

6.  Clarification of risk factors for abdominal operations in patients with hepatic cirrhosis.

Authors:  R N Garrison; H M Cryer; D A Howard; H C Polk
Journal:  Ann Surg       Date:  1984-06       Impact factor: 12.969

7.  Biliary tract surgery and cirrhosis: a critical combination.

Authors:  S I Schwartz
Journal:  Surgery       Date:  1981-10       Impact factor: 3.982

8.  A United States compassionate use study of lamivudine treatment in nontransplantation candidates with decompensated hepatitis B virus-related cirrhosis.

Authors:  Hie-Won L Hann; Robert J Fontana; Teresa Wright; Gregory Everson; Alfred Baker; Eugene R Schiff; Carolyn Riely; Gaya Anschuetz; Stephen D Gardner; Nathaniel Brown; Dorothea Griffiths
Journal:  Liver Transpl       Date:  2003-01       Impact factor: 5.799

9.  Results of esophagogastrectomy for carcinoma in cirrhotic patients. A series of 23 consecutive patients.

Authors:  F Fekete; J Belghiti; D Cherqui; F Langonnet; B Gayet
Journal:  Ann Surg       Date:  1987-07       Impact factor: 12.969

10.  Cholecystectomy in cirrhotic patients: a formidable operation.

Authors:  G V Aranha; S J Sontag; H B Greenlee
Journal:  Am J Surg       Date:  1982-01       Impact factor: 2.565

View more
  7 in total

Review 1.  Endoscopic submucosal dissection in early gastric cancer in elderly patients and comorbid conditions.

Authors:  Tsutomu Nishida; Motohiko Kato; Toshiyuki Yoshio; Tomofumi Akasaka; Teppei Yoshioka; Tomoki Michida; Masashi Yamamoto; Shiro Hayashi; Yoshito Hayashi; Masahiko Tsujii; Tetsuo Takehara
Journal:  World J Gastrointest Endosc       Date:  2015-05-16

2.  Endoscopic Submucosal Dissection of Early Gastric Cancer in Patients with Liver Cirrhosis.

Authors:  Won Hyeok Choe; Jeong Hwan Kim; Jung Ho Park; Heung Up Kim; Dae Hyeon Cho; Sang Pyo Lee; Tae Yoon Lee; Sun-Young Lee; In Kyung Sung; Hyung Seok Park; Chan Sup Shim
Journal:  Dig Dis Sci       Date:  2017-12-27       Impact factor: 3.199

3.  Gastric cancer surgery for patients with liver cirrhosis.

Authors:  Yoshiyuki Ikeda; Tatsuo Kanda; Shin-Ichi Kosugi; Kazuhito Yajima; Atsushi Matsuki; Tsutomu Suzuki; Katsuyoshi Hatakeyama
Journal:  World J Gastrointest Surg       Date:  2009-11-30

4.  Outcomes of ESD for patients with early gastric cancer and comorbid liver cirrhosis: a propensity score analysis.

Authors:  Motohiko Kato; Tsutomu Nishida; Toshimitsu Hamasaki; Naoki Kawai; Toshiyuki Yoshio; Satoshi Egawa; Katsumi Yamamoto; Hideharu Ogiyama; Masato Komori; Masanori Nakahara; Takamasa Yabuta; Akihiro Nishihara; Yoshito Hayashi; Takuya Yamada; Tetsuo Takehara
Journal:  Surg Endosc       Date:  2014-10-08       Impact factor: 4.584

5.  Safety of laparoscopic radical gastrectomy in gastric cancer patients with liver cirrhosis.

Authors:  Dong Jin Kim; Cho Hyun Park; Wook Kim; Hyung Min Jin; Jin Jo Kim; Han Hong Lee; Jun Hyun Lee
Journal:  Surg Endosc       Date:  2017-02-15       Impact factor: 4.584

6.  Clinical outcomes of patients with liver cirrhosis who underwent curative surgery for gastric cancer: a retrospective multi-center study.

Authors:  Hyun Joo Jang; Jung Han Kim; Hun Ho Song; Kyung Hee Woo; Mi Kim; Sea Hyub Kae; Jin Lee; Ji Wong Cho; Jung Hun Kang; Soon Il Lee; Soo Jung Gong; Jung Ae Lee; Dae Young Zang
Journal:  Dig Dis Sci       Date:  2007-06-28       Impact factor: 3.199

7.  Comparison of long-term survival and immediate postoperative liver function after laparoscopic and open distal gastrectomy for early gastric cancer patients with liver cirrhosis.

Authors:  Amer Saeed Alshahrani; Ghung-Sik Gong; Moon-Won Yoo
Journal:  Gastric Cancer       Date:  2016-12-10       Impact factor: 7.370

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.